Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Fair Isaac Corp. Stock Rallies 7.7%, Outperforms Peers

Fair Isaac Corp. Stock Rallies 7.7%, Outperforms Peers

Dow JonesDow Jones2026/08/19 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Fair Isaac Corp. rose 7.7% to $1,161.59 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.2% to 7,707.98 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.

This was the stock's second consecutive day of gains.

Fair Isaac Corp. closed 41.9% below its 52-week high of $1,998.01, which the company achieved on October 2nd.

The stock outperformed some of its peers, as International Business Machines Corp. rose 1.9% to $237.16, Fiserv Inc. rose 0.7% to $52.08, and ACI Worldwide Inc. fell 0.38% to $51.97.

Trading volume totaled 357,808, compared to the 50-day average of 327,075.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 19, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11